In this study, we comprehensively evaluated the clinical, and immunological profiles of a 12-year-old boy carrying a de novo ALPK1 mutation and presenting with manifestations consistent with ROSAH syndrome. This evidence concerns the gene ALPK1 and retinal dystrophy, optic nerve edema, splenomegaly, anhidrosis, and migraine headache syndrome.